Pure Scutellaria Baicalensis Root Extract Powder Pharmaceutical Grade

• Customization: Available
• Certification: ISO, Halal
• Assay Method: HPLC-MS, HPLC
• Model NO.: NY016
• Application Form: Tablet, Capsule, Softgels, Tinctures, Liquids, Drops
• Application: Food, Medicine
• State: Powder
• Extract Source: Stem and Leaf
• Particle Size: 100% Through 80 Mesh
• Bulk Density: 0.4-0.6g/Ml
• Solvent Residue: Negative
• Loss on Drying: ≤5%
• Transport Package: 25kg/Dull
• Specification: 98%
• Trademark: Nutrayours/ OEM
• Origin: China
• HS Code: 1302199099
• Production Capacity: 3000kg/Year

Product Description

 

About this item

• 100% NATURAL PRODUCT: No artificial colors or flavors
• Verified herb identity, confirmed highest quality of raw herb and the extract
• Best natural sources of herbs and raw materials: Every vendor is carefully picked to meet our high standards
• Third-party lab tested, pure Natural Scutellaria baicalensis Extract

Scutellaria baicalensis extract, also known as Chinese skullcap, is a traditional Chinese medicine used for various conditions. It has demonstrated anti-inflammatory, antioxidant, and anticancer properties in lab studies. Research suggests it may be beneficial for treating arthritis, some types of cancer, and potentially even erectile dysfunction. 


Product Description
   

Product name	Chinese skullcap herb 80% scutellaria baicalensis extract 2167-41-9
Part used	Dry Roots of Scutellaria baicalensis
Shape and properties	Light yellow powder, odorless and bitter
Specification Ingredient	Baicalin 80%
Molecular formula	C21H18O11
Test method	HPLC
CAS number	21967-41-9
Product packaging	25 kg per fiber drum or according to customer requirements
Storage condition	Should be sealed and shaded. Store in a dry, cool and well ventilated place. For 24 months

Function and efficacy

• Anti-inflammatory:

  S. baicalensis and its active compounds like baicalein and baicalin can inhibit the production of inflammatory cytokines and mediators, potentially aiding in conditions like arthritis and allergies. 

   
• Antioxidant:

  The extract possesses antioxidant properties, which may help protect cells from damage caused by free radicals. 

   
• Anticancer:

  Studies have shown that S. baicalensis can induce cell death in some cancer cell lines, and may have a role in preventing tumor growth by inhibiting angiogenesis (blood vessel formation in tumors). 

   
• Potential erectile dysfunction treatment:

  Research suggests it may have a role in treating erectile dysfunction by promoting relaxation of the penile smooth muscle. 

   
• Neuroprotective effects:

  The herb and its components, like baicalin, have shown promise in protecting against neurodegenerative diseases and seizures in animal models. 

   
• Antiallergic:

  S. baicalensis can inhibit mast cell degranulation and histamine release, potentially alleviating symptoms of allergic reactions. 

   
• Cardiovascular benefits:

  Baicalein and wogonin, found in S. baicalensis, may inhibit collagen deposition and improve metabolic disorders. 

   
• Possible drug interactions:

  It's important to note that S. baicalensis can interact with other medications, affecting their absorption, distribution, metabolism, and elimination. 

   

Important Considerations:

• Limited human studies:

  .Opens in new tab

  While promising, more research, especially in humans, is needed to fully understand the effectiveness and safety of S. baicalensis for various conditions. 

   
• Potential side effects and drug interactions:

  .Opens in new tab

  It's crucial to be aware of possible side effects and interactions with other medications before using S. baicalensis. 

   
• Consult a healthcare professional:

  .Opens in new tab

  It's recommended to consult with a doctor or qualified healthcare professional before using S. baicalensis, especially if you have any underlying health conditions or are taking other medications. 

 

About us

* The statements in this section have not been evaluated by the FDA or EFSA.


References

1.Wang ZL, Wang S, Kuang Y, Hu ZM, Qiao X, Ye M.Pharm Biol. 2018 Dec;56(1):465-484. doi: 10.1080/13880209.2018.1492620.PMID: 31070530


2.Gasiorowski K, Lamer-Zarawska E, Leszek J, Parvathaneni K, Yendluri BB, Błach-Olszewska Z, Aliev G.CNS Neurol Disord Drug Targets. 2011 Mar;10(2):184-91. doi: 10.2174/187152711794480384.PMID: 21222632

3.Wang PW, Lin TY, Yang PM, Fang JY, Li WT, Pan TL.Biomed Pharmacother. 2022 Nov;155:113798. doi: 10.1016/j.biopha.2022.113798. Epub 2022 Oct 4.PMID: 36271574


4.Fan Y, Wu D, Zhang S.Molecules. 2021 Apr 16;26(8):2322. doi: 10.3390/molecules26082322.
PMID: 33923637 

5.Chen Q, Liu M, Yu H, Li J, Wang S, Zhang Y, Qiu F, Wang T.J Nat Med. 2018 Jun;72(3):655-666. doi: 10.1007/s11418-018-1199-5. Epub 2018 Mar 14.PMID: 29542003